Colony opacity, hemadsorption, hemolysis, and mitogenicity are not associated with virulence of Mycoplasma pulmonis.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 259540)

Published in Infect Immun on August 01, 1988

Authors

M K Davidson1, S E Ross, J R Lindsey, G H Cassell

Author Affiliations

1: Department of Comparative Medicine, University of Alabama, Birmingham.

Articles by these authors

Rescue of signaling by a chimeric protein containing the cytoplasmic domain of CD45. Science (1993) 4.47

Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants. Lancet (1988) 3.47

The role of C/EBP genes in adipocyte differentiation. J Biol Chem (1998) 3.30

Mycoplasmas as agents of human disease. N Engl J Med (1981) 3.28

The complete sequence of the mucosal pathogen Ureaplasma urealyticum. Nature (2000) 3.01

Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis. Am J Pathol (1971) 2.66

Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol (2000) 2.54

Detection of antibodies to Mycoplasma pulmonis by an enzyme-linked immunosorbent assay. Infect Immun (1978) 2.50

Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med (1998) 2.45

Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J (1995) 2.44

Mild head injury: a plea for routine early CT scanning. J Trauma (1992) 2.29

In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. Antimicrob Agents Chemother (1988) 2.29

Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. Proc Natl Acad Sci U S A (1998) 2.22

Heterogeneity among strains and a high rate of variation within strains of a major surface antigen of Mycoplasma pulmonis. Infect Immun (1988) 2.21

A link between chronic asthma and chronic infection. J Allergy Clin Immunol (2001) 2.18

The role of environmental ammonia in respiratory mycoplasmosis of rats. Am J Pathol (1976) 2.15

Experimental Mycoplasma pulmonis infection in pathogen-free mice. Models for studying mycoplasmosis of the respiratory tract. Am J Pathol (1973) 2.14

Mycoplasma pulmonis and lymphoma in bioassays in rats. Vet Pathol (2009) 2.03

Transposition of gram-positive transposon Tn916 in Acholeplasma laidlawii and Mycoplasma pulmonis. Science (1987) 1.96

Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse. Hum Mol Genet (2001) 1.93

The clinical utility of computed tomographic scanning and neurologic examination in the management of patients with minor head injuries. J Trauma (1992) 1.91

In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. Antimicrob Agents Chemother (1991) 1.90

Detection of Ureaplasma urealyticum by polymerase chain reaction in the urogenital tract of adults, in amniotic fluid, and in the respiratory tract of newborns. Clin Infect Dis (1993) 1.88

Small repeating units within the Ureaplasma urealyticum MB antigen gene encode serovar specificity and are associated with antigen size variation. Infect Immun (1995) 1.84

Infection and labor. VII. Microbial invasion of the amniotic cavity in spontaneous rupture of membranes at term. Am J Obstet Gynecol (1992) 1.82

Derrick Edward Award Lecture. The pathogenic potential of mycoplasmas: Mycoplasma pulmonis as a model. Rev Infect Dis (1982) 1.76

Implication of the GRB2-associated phosphoprotein SLP-76 in T cell receptor-mediated interleukin 2 production. J Exp Med (1996) 1.75

Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am J Pathol (1998) 1.69

Variable antigens of Ureaplasma urealyticum containing both serovar-specific and serovar-cross-reactive epitopes. Infect Immun (1990) 1.65

Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis (1984) 1.64

The spectrum of blunt injury to the carotid artery: a multicenter perspective. J Trauma (1994) 1.62

Autosomal dominant erythromelalgia. Am J Med Genet (1992) 1.61

Signaling pathways through which insulin regulates CCAAT/enhancer binding protein alpha (C/EBPalpha) phosphorylation and gene expression in 3T3-L1 adipocytes. Correlation with GLUT4 gene expression. J Biol Chem (1997) 1.60

Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study. Pediatrics (1981) 1.57

Attachment of mycoplasmas to erythrocytes: a model to study mycoplasma attachment to the epithelium of the host respiratory tract. Isr J Med Sci (1981) 1.56

p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha. J Biol Chem (2001) 1.56

Differences in virulence for mice among strains of Mycoplasma pulmonis. Infect Immun (1988) 1.54

Immune response of pathogen-free mice inoculated intranasally with Mycoplasma pulmonis. J Immunol (1974) 1.54

Variations in the surface proteins and restriction enzyme systems of Mycoplasma pulmonis in the respiratory tract of infected rats. Mol Microbiol (2001) 1.54

Sequence analysis of the chromosomal region around and within the V-1-encoding gene of Mycoplasma pulmonis: evidence for DNA inversion as a mechanism for V-1 variation. Infect Immun (1996) 1.53

Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection. Pediatr Infect Dis J (1994) 1.53

Selective association of murine T lymphoblastoid cell surface alloantigens with Mycoplasma hyorhinis. Proc Natl Acad Sci U S A (1978) 1.53

Mycoplasma infections as models of chronic joint inflammation. Arthritis Rheum (1979) 1.51

Serotype diversity and antigen variation among invasive isolates of Ureaplasma urealyticum from neonates. Infect Immun (1992) 1.50

Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease. Infect Immun (1995) 1.50

Identification of cross-reactive antigens between Mycoplasma pulmonis and Mycoplasma arthritidis. Infect Immun (1984) 1.49

Isolation of Mycoplasma pulmonis membranes and identification of surface antigens. Infect Immun (1987) 1.49

Strain differences in susceptibility to murine respiratory mycoplasmosis in C57BL/6 and C3H/HeN mice. Infect Immun (1985) 1.49

Murine respiratory mycoplasmosis in F344 and LEW rats: evolution of lesions and lung lymphoid cell populations. Infect Immun (1982) 1.49

Development of an aerosol model of murine respiratory mycoplasmosis in mice. Infect Immun (1986) 1.48

The concept, design, and operation of a radiological health science education unit. Radiology (1971) 1.46

Minor head injury: a proposed strategy for emergency management. Ann Emerg Med (1993) 1.46

Multichamber gunshot wounds of the heart. The utility of transesophageal echocardiography. Chest (1992) 1.45

Incidence of infectious drug resistance among fecal coliforms isolated from raw sewage. Appl Microbiol (1971) 1.45

Roles of innate and adaptive immunity in respiratory mycoplasmosis. Infect Immun (1998) 1.44

Protective effect of vaccination against Mycoplasma pulmonis respiratory disease in rats. Infect Immun (1978) 1.43

Ureaplasma urealyticum biovar specificity and diversity are encoded in multiple-banded antigen gene. J Clin Microbiol (1994) 1.42

Desensitization of Ras activation by a feedback disassociation of the SOS-Grb2 complex. J Biol Chem (1995) 1.42

Equine goiter due to excess dietary iodide. J Am Vet Med Assoc (1968) 1.41

Detection of natural Mycoplasma pulmonis infection in rats and mice by an enzyme linked immunosorbent assay (ELISA). Lab Anim Sci (1981) 1.41

Amniotic fluid interleukin-6: correlation with upper genital tract microbial colonization and gestational age in women delivered after spontaneous labor versus indicated delivery. Am J Obstet Gynecol (1995) 1.40

Pathogen status in the 1990s: abused terminology and compromised principles. Lab Anim Sci (1998) 1.38

Murine respiratory mycoplasmosis in LEW and F344 rats: strain differences in lesion severity. Vet Pathol (1982) 1.37

Adsorption of mycoplasma virus P1 to host cells. J Bacteriol (1988) 1.37

Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect Immun (1995) 1.36

Isolation of a virus from Mycoplasma pulmonis. Isr J Med Sci (1987) 1.36

Neuronal GM1 gangliosidosis in a Siamese cat with beta-galactosidase deficiency. Science (1971) 1.35

Interactions between murine alveolar macrophages and Mycoplasma pulmonis in vitro. Infect Immun (1980) 1.35

Conservative management of duodenal trauma: a multicenter perspective. J Trauma (1990) 1.34

Tyrosines 113, 128, and 145 of SLP-76 are required for optimal augmentation of NFAT promoter activity. J Immunol (1996) 1.34

Feline GM 1 gangliosidosis: biochemical and ultrastructural comparisons with the disease in man. J Neuropathol Exp Neurol (1973) 1.32

The double papillae repositioned flap in periodontal therapy. J Periodontol (1968) 1.32

An inhibitory monoclonal antibody against human tissue factor. Blood (1987) 1.30

Nonspecific lymphocyte responses in F344 and LEW rats: susceptibility to murine respiratory mycoplasmosis and examination of cellular basis for strain differences. Infect Immun (1985) 1.29

Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite. Proc Natl Acad Sci U S A (1999) 1.29

Multiphasic interactions of Mycoplasma pulmonis with erythrocytes defined by adherence and hemagglutination. Infect Immun (1984) 1.28

Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population. Pediatr Infect Dis J (1990) 1.27

High-frequency variation in Mycoplasma pulmonis colony size. J Bacteriol (1989) 1.26

Mycoplasma pulmonis V-1 surface protein variation: occurrence in vivo and association with lung lesions. Microb Pathog (1989) 1.26

Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice. Infect Immun (1987) 1.26

Role of Ureaplasma urealyticum and other pathogens in the development of chronic lung disease of prematurity. Pediatr Infect Dis J (1988) 1.25

Respiratory and genital mycoplasmosis of laboratory rodents: implications for biomedical research. Isr J Med Sci (1981) 1.25

Measurement of antibody to Ureaplasma urealyticum by an enzyme-linked immunosorbent assay and detection of antibody responses in patients with nongonococcal urethritis. J Clin Microbiol (1983) 1.24

Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice. Infect Immun (1997) 1.24

DRG reimbursement for trauma: the demise of the trauma center (the use of ISS grouping as an early predictor of total hospital cost). J Trauma (1988) 1.21

Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newborn. Pediatrics (1989) 1.21

Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J (1998) 1.21

Intracage ammonia promotes growth of Mycoplasma pulmonis in the respiratory tract of rats. Infect Immun (1982) 1.20

Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease. Clin Infect Dis (1998) 1.19

Acute posttraumatic renal failure: a multicenter perspective. J Trauma (1991) 1.18

Delayed brain injury after head trauma: significance of coagulopathy. Neurosurgery (1992) 1.18